)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
)
Uniting senior legal leaders from across pharma, biotech and the broader life science sector, LSLS 2027 will once again dive into practical and lived experiences of practitioners discussing the overall life science strategy sector, including IP, exclusivity, market access, transactions, competition and compliance. Get ready for nuanced debate, actionable takeaways and senior networking opportunities, which will help you sharpen your legal strategy and establish key contacts tailored to your work.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Holistic Keynote Discussions
Learn how the industry is responding to cross-practice challenges, from loss of exclusivity and the rise of AI to the EU Pharma Package, geopolitics and Europe's place in the global life science market. Featuring insights from General Counsel, senior policymakers, private practice experts and more.
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)